Two panelists represent AReNA at Leyton Connect’s 5-to-7

On March 4, 2025, Xavier Linker, Director of Strategic Initiatives at AReNA, as well as Sam Osseiran, PhD, RNA Entrepreneurship Director (Axelys), participated as panelists at the Leyton Connect 5-to-7: RNA Technologies – Beyond COVID Vaccines.
Alongside Claude LeDuc (RNA Technologies and Therapeutics), George Elvira (Gowling WLG) and Giovanna Sebastiani McGill University D2R | de l’ADN à l’ARN,, insightful discussions took place around key topics:
- Beyond COVID vaccines: What are the different RNA technologies?
- RNA industry players: Who is shaping this sector in Quebec and Canada?
- Academia & industry: A new paradigm for collaboration?
- Intellectual property: Are new ways of thinking emerging?
- Funding & competitiveness: What strategies can position Quebec and Canada on the global stage?

